Results 81 to 90 of about 6,010 (179)
Respiratory Medicine Case Reports, 2018 Clinical efficacy of combination therapy using vasodilators for pulmonary arterial hypertension (PAH) is well established. However, information on its safety are limited.
Kimikazu Takeuchi +11 more
doaj +1 more source
, 2008 Objective: Prostacyclins have been suggested to exert positive inotropic effects which would render them particularly suitable for the treatment of right ventricular (RV) dysfunction due to acute pulmonary hypertension (PHT).
Missant, Carlo +6 more
core +1 more source
MODERN PHARMACEUTICAL TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
Российский кардиологический журнал, 2009 The review is devoted to modern pharmaceutical treatment of pulmonary arterial hypertension (PAH). In 1970-80s, it was based on high-dose calcium antagonists, CAs (e.g., nifedipine 240 mg/d), which were effective only in some patients with primary ...
D. V. Preobrazhensky +5 more
doaj
Use of aerosolized inhaled epoprostenol in the treatment of portopulmonary hypertension
, 2000 Background. Portopulmonary hypertension is a known complication in the liver transplant candidate. Intravenous epoprostenol has been demonstrated to decrease pulmonary artery pressures and possibly remodel right ventricle geometry. Methods.
Rafii, Amir A. +5 more
core +1 more source
Modern pharmaceutical treatment of pulmonary arterial hypertension
Кардиоваскулярная терапия и профилактика, 2008 The review is devoted to modern pharmaceutical treatment of pulmonary arterial hypertension (PAH). In 1970-80s, it was based on high-dose calcium antagonists, CA (e.g., nifedipine 240 mg/d), which were effective only in some patients with primary ...
T. A. Batyraliev +4 more
doaj
, 2009 Primary pulmonary hypertension (PPH) is a progressive disease for which them e is no cure. Continuous intravenous infusion of epoprostenol in selected patients with advanced PPH improves symptoms and survival, but the long-term impact has not been ...
LEE, YUNG-CHIE;HUANG, SHU-CHIEN;KUO, SHUENN-WEN;KO, WEN-JE;CHIANG, FU-TIEN +1 more
core
Inhaled vasodilators nitric oxide and epoprostenol may be initiated to improve oxygenation in mechanically ventilated patients with severe acute respiratory failure; however, practice patterns and head-to-head comparisons of effectiveness are unclear ...
Vail, Emily A. +6 more
core +1 more source
Hypocalcemia after Denosumab in a Pulmonary Hypertension Patient Receiving Epoprostenol
, 2017 We report the case of a 50-year-old woman with anorexigen-induced pulmonary arterial hypertension treated with epoprostenol, who presented with Trousseau’s sign, leading to the diagnosis of severe hypocalcemia for which substitution was started ...
Benedicte De Muynck +5 more
core +2 more sources
Prostanoid therapies in the management of pulmonary arterial hypertension
Therapeutics and Clinical Risk Management, 2015 Barbara L LeVarge Department of Pulmonary and Critical Care Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA Abstract: Prostacyclin is an endogenous eicosanoid produced by endothelial cells; through actions on vascular smooth-muscle ...
LeVarge BL
doaj